Targeting the Ras palmitoylation/depalmitoylation cycle in cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Ras proteins are key drivers in numerous cancers, making them significant therapeutic targets.
• Previous attempts to inhibit Ras by blocking farnesylation have been unsuccessful in clinical trials.
• Ras proteins undergo lipid modifications, including S-acylation (palmitoylation), which are crucial for their function.

Purpose of the Study:

• To explore S-acylation (palmitoylation) as a novel strategy for targeting Ras proteins in cancer.
• To review enzymes responsible for palmitoylation and depalmitoylation of Ras proteins.
• To identify other proteins influencing Ras localization as potential drug targets.

Main Methods:

• Literature review of Ras lipid modifications and associated enzymes.
• Analysis of the role of palmitoylation in Ras membrane association and function.
• Examination of proteins affecting Ras localization.

Main Results:

• S-acylation (palmitoylation) is a critical modification for Ras protein membrane localization and function.
• Enzymes involved in palmitoylation and depalmitoylation play regulatory roles in Ras-driven tumorigenesis.
• Other proteins interacting with Ras may represent alternative therapeutic targets.

Conclusions:

• Targeting Ras palmitoylation presents a promising alternative strategy for anticancer drug development.
• Understanding the enzymes and interacting proteins involved in Ras localization is crucial for developing effective Ras-targeted therapies.
• This approach may overcome the clinical trial failures associated with farnesyltransferase inhibitors.